Wafford KA - Search Results

1

Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time.

Wafford KA, Ebert B. Wafford KA, et al. Nat Rev Drug Discov. 2008 Jun;7(6):530-40. doi: 10.1038/nrd2464. Epub 2008 May 23. Nat Rev Drug Discov. 2008. PMID: 18511929 Review.

2

Gaboxadol--a new awakening in sleep.

Wafford KA, Ebert B. Wafford KA, et al. Curr Opin Pharmacol. 2006 Feb;6(1):30-6. doi: 10.1016/j.coph.2005.10.004. Epub 2005 Dec 20. Curr Opin Pharmacol. 2006. PMID: 16368265 Review.

3

Treating insomnia: Current and investigational pharmacological approaches.

Ebert B, Wafford KA, Deacon S. Ebert B, et al. Among authors: wafford ka. Pharmacol Ther. 2006 Dec;112(3):612-29. doi: 10.1016/j.pharmthera.2005.04.014. Epub 2006 Jul 28. Pharmacol Ther. 2006. PMID: 16876255 Review.

4

Distinct activities of GABA agonists at synaptic- and extrasynaptic-type GABAA receptors.

Mortensen M, Ebert B, Wafford K, Smart TG. Mortensen M, et al. J Physiol. 2010 Apr 15;588(Pt 8):1251-68. doi: 10.1113/jphysiol.2009.182444. Epub 2010 Feb 22. J Physiol. 2010. PMID: 20176630 Free PMC article.

5

Pharmacology of GABA(A) receptors exhibiting different levels of spontaneous activity.

Mortensen M, Wafford KA, Wingrove P, Ebert B. Mortensen M, et al. Among authors: wafford ka. Eur J Pharmacol. 2003 Aug 22;476(1-2):17-24. doi: 10.1016/s0014-2999(03)02125-3. Eur J Pharmacol. 2003. PMID: 12969744

6

Bioisosteric determinants for subtype selectivity of ligands for heteromeric GABA(A) receptors.

Ebert B, Mortensen M, Thompson SA, Kehler J, Wafford KA, Krogsgaard-Larsen P. Ebert B, et al. Among authors: wafford ka. Bioorg Med Chem Lett. 2001 Jun 18;11(12):1573-7. doi: 10.1016/s0960-894x(01)00184-6. Bioorg Med Chem Lett. 2001. PMID: 11412984

7

The delta subunit of gamma-aminobutyric acid type A receptors does not confer sensitivity to low concentrations of ethanol.

Borghese CM, Stórustovu Sí, Ebert B, Herd MB, Belelli D, Lambert JJ, Marshall G, Wafford KA, Harris RA. Borghese CM, et al. Among authors: wafford ka. J Pharmacol Exp Ther. 2006 Mar;316(3):1360-8. doi: 10.1124/jpet.105.092452. Epub 2005 Nov 4. J Pharmacol Exp Ther. 2006. PMID: 16272217

8

Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.

Ebert B, Wafford KA, Whiting PJ, Krogsgaard-Larsen P, Kemp JA. Ebert B, et al. Among authors: wafford ka. Mol Pharmacol. 1994 Nov;46(5):957-63. Mol Pharmacol. 1994. PMID: 7969086

9

Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human gamma-aminobutyric acid type A receptors.

Ebert B, Thompson SA, Saounatsou K, McKernan R, Krogsgaard-Larsen P, Wafford KA. Ebert B, et al. Among authors: wafford ka. Mol Pharmacol. 1997 Dec;52(6):1150-6. Mol Pharmacol. 1997. PMID: 9396785

10

Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression.

Wood CM, Wafford KA, McCarthy AP, Hewes N, Shanks E, Lodge D, Robinson ESJ. Wood CM, et al. Among authors: wafford ka. Neuropharmacology. 2018 Sep 15;140:246-259. doi: 10.1016/j.neuropharm.2018.07.013. Epub 2018 Jul 11. Neuropharmacology. 2018. PMID: 30005976 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page